Treatment for brain metastases: ASCO-SNO-ASTRO guideline
MA Vogelbaum, PD Brown, H Messersmith… - 2022 - academic.oup.com
Purpose To provide guidance to clinicians regarding therapy for patients with brain
metastases from solid tumors. Methods ASCO convened an Expert Panel and conducted a …
metastases from solid tumors. Methods ASCO convened an Expert Panel and conducted a …
[HTML][HTML] The different central nervous system efficacy among gefitinib, erlotinib and afatinib in patients with epidermal growth factor receptor mutation-positive non …
HA Jung, SY Woo, SH Lee, JS Ahn… - Translational Lung …, 2020 - ncbi.nlm.nih.gov
Background Brain metastasis is common in non-small cell lung cancer (NSCLC) and has an
even higher incidence in epidermal growth factor receptor (EGFR)-mutant cancers. Although …
even higher incidence in epidermal growth factor receptor (EGFR)-mutant cancers. Although …
Antioxidant activity of erlotinib and gefitinib: theoretical and experimental insights
SH K. P, TD Babu, P C. M, G Joshy… - Free Radical …, 2022 - Taylor & Francis
Erlotinib and gefitinib are quinazoline derivatives with antineoplastic properties. Usually,
intake of antineoplastic agents results in much a greater degree of oxidative stress, ie the …
intake of antineoplastic agents results in much a greater degree of oxidative stress, ie the …
肺癌脑转移中国治疗指南(2021 年版).
石远凯 - Chinese Journal of Oncology, 2021 - search.ebscohost.com
DOI:10.1002/ijc.32486. [205] de Koning HJ, Page 1 DOI:10.1002/ijc.32486. [205] de Koning
HJ, van der Aalst CM, de Jong PA, et al. Reduced lung⁃cancer mortality with volume CT …
HJ, van der Aalst CM, de Jong PA, et al. Reduced lung⁃cancer mortality with volume CT …
[HTML][HTML] RET 融合型非小细胞肺癌的研究进展
郑玉军， 姜巍， 陈东妍， 李颜君， 代璐璐… - Chinese Journal of …, 2021 - ncbi.nlm.nih.gov
过去的20 年来， 随着分子生物学研究的不断进展， 非小细胞肺癌(non-small cell lung cancer,
NSCLC) 的治疗方法不断发展， 靶向治疗使驱动基因突变阳性患者的生存期得到了改善 …
NSCLC) 的治疗方法不断发展， 靶向治疗使驱动基因突变阳性患者的生存期得到了改善 …
Sailing through lung cancer charted by EGFR signposts
SK Mullapally, J Revendran - Cancer Research, Statistics, and …, 2019 - journals.lww.com
The review article on the epidermal growth factor receptor (EGFR)‑mutated non‑small cell
lung cancer (NSCLC) has been read with great interest by us from the oncology and …
lung cancer (NSCLC) has been read with great interest by us from the oncology and …
Research Progress of Fusion Genes RET in Non-small Cell Lung Cancer.
Y Zheng, W Jiang, C Dongyan… - Chinese Journal of …, 2021 - search.ebscohost.com
In the past 20 years, with the development of molecular biology, the treatment of non-small
cell lung cancer (NSCLC) has been developing. Targeted therapy has improved the survival …
cell lung cancer (NSCLC) has been developing. Targeted therapy has improved the survival …
Author Reply to: Sahoo, Batra: et al:. and Mullapally: et al:.
Dear Editor, We thank Dr. Sahoo,[1] Dr. Batra et al.,[2] and Dr. Mullapally and Revendran.[3]
for their thoughtful letters regarding our review on epidermal growth factor receptor (EGFR) …
for their thoughtful letters regarding our review on epidermal growth factor receptor (EGFR) …